Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Protara Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- 0 vs. Q3 2022
- Shares held
- 5.48M
- −180.2K (−3.2%) vs. Q3 2022
- Total value
- $14.7M
- −$2.04M (−12.2%) vs. Q3 2022
- New holders
- 3
- 6 more added
- Sold out
- 3
- 10 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 133 | $0 | 0.00% | +133 | New |
| Bank of America Corp | 22 | $58 | 0.00% | +22 | New |
| Morgan Stanley | 25 | $67 | 0.00% | −219−89.8% | Reduced |
| Advisor Group Holdings, Inc. | 100 | $268 | 0.00% | +100 | New |
| Federated Hermes, Inc. | 124 | $332 | 0.00% | −122−49.6% | Reduced |
| Wells Fargo & Company | 559 | $1.50K | 0.00% | +1+0.2% | Added |
| UBS Group AG | 2,300 | $6.16K | 0.00% | +2,061+862.3% | Added |
| Acadian Asset Management LLC | 6,314 | $16.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,848 | $39.8K | 0.00% | −155,674−91.3% | Reduced |
| Dimensional Fund Advisors LP | 16,834 | $45.0K | 0.00% | +1,052+6.7% | Added |
| Assenagon Asset Management S.A. | 17,336 | $46.0K | 0.00% | −41,053−70.3% | Reduced |
| Bank of New York Mellon Corp | 17,907 | $48.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 18,864 | $50.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 20,019 | $53.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 29,626 | $79.0K | 0.00% | −20,581−41.0% | Reduced |
| State Street Corp | 30,900 | $82.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 36,360 | $97.4K | 0.00% | +859+2.4% | Added |
| Two Sigma Investments, LP | 46,147 | $123.7K | 0.00% | −4,901−9.6% | Reduced |
| Two Sigma Advisers, LP | 47,218 | $126.5K | 0.00% | −5,200−9.9% | Reduced |
| Bridgeway Capital Management, LLC | 64,000 | $171.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 67,000 | $180.0K | 0.00% | −12,200−15.4% | Reduced |
| Geode Capital Management, LLC | 83,420 | $223.0K | 0.00% | −224−0.3% | Reduced |
| Privium Fund Management (UK) Ltd | 119,730 | $320.9K | 0.24% | +84,730+242.1% | Added |
| Ikarian Capital, LLC | 188,664 | $505.6K | 0.21% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $535.1K | 0.00% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $560.7K | 0.03% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 290,051 | $777.3K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 427,612 | $1.15M | 0.00% | +224+0.1% | Added |
| OrbiMed Advisors LLC | 830,641 | $2.23M | 0.04% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,692,594 | $7.22M | 2.51% | −15,473−0.6% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,465−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −1,161−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |